Mueller, M.* ; Blandino, A.* ; Scherer, D.* ; Zulantay, I.* ; Apt, W.* ; Varela, N.M.* ; Llancaqueo, M.* ; Garcia, L.* ; Ortiz, L.* ; Nicastri, E.* ; Giancola, M.L.* ; Angheben, A.* ; Gabrielli, S.* ; Rounge, T.B.* ; Langseth, H.* ; Waldenberger, M. ; Salinas-Alvarez, P.* ; Bermejo, J.L.*
Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease.
J. Infect. 91:106613 (2025)
BACKGROUND: Chagas disease, caused by the parasite Trypanosoma cruzi (T. cruzi), affects around 6-7 million people in Latin America and hundreds of thousands in the United States and Europe. A main complication of chronic Chagas disease is cardiomyopathy, possibly manifesting as arrhythmias, heart failure, or sudden cardiac death. Understanding the link between T. cruzi infection and cardiomyopathy is essential for early diagnosis and adequate treatment. METHODS: We sequenced small RNAs in serum samples from 228 Chagas patients recruited in Chile, Bolivia and Italy. After bioinformatic processing of sequencing data to quantify serum miRNA expression, robust logistic regression was applied to identify miRNAs differentially expressed in Chagas patients with abnormalities in electrocardiography (ECG), bundle-branch block on ECG, and high Kuschnir scores. We also investigated the association between genotype-based miRNA expression and the risk of abnormal ECG findings. FINDINGS: As reported, the risk of abnormal ECG findings was higher in male patients and increased with age. Three miRNAs showed lower serum expression levels in patients with abnormal ECG: miRNA-101-3p, miRNA-576-3p and miRNA-629-5p (p < 0.0002), especially in patients with high Kuschnir scores. The expression of miRNA-629-5p was negatively correlated with the CCL5 expression (p = 3.7×10-8), a chemokine frequently reported in Chagas disease, gene enrichment analyses indicated involvement of cytokine signalling in Chagas cardiomyopathy. INTERPRETATION: The findings demonstrate the potential of circulating miRNAs as diagnostic biomarkers for Chagas cardiomyopathy. The associations found with disease severity and immune response may help to improve our knowledge of complications' development in Chagas disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Biomarkers ; C-c Motif Chemokine Ligand 5 (ccl5) ; Cardiomyopathy ; Chagas ; Microrna ; Small-rna Sequencing; Randomized-trial; Heart-failure; Cardiomyopathy; Ccl5; Benznidazole; Diagnosis; Profile; Panther; Design
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0163-4453
e-ISSN
0163-4453
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 91,
Heft: 4,
Seiten: ,
Artikelnummer: 106613
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
32 Jamestown Rd, London Nw1 7by, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504091-001
Förderungen
Italian Ministry of Health "Ricerca Corrente-L2" to IRCCS Sacro Cuore Don Calabria Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Boston University
Division of Intramural Research, NHLBI
Center for Population Studies, NHLBI
NIH/NHLBI
Baden-Wuerttemberg Ministry of Science, Research, and the Arts (MWK)
German Research Foundation (DFG)
Research Council of Norway
South-Eastern Regional Health Authority
EU-LAC Health project
Copyright
Erfassungsdatum
2025-10-10